The pathogenesis of ACTA1‐related congenital fiber type disproportion
Authors:
- Sandra CooperSCSandra Cooper
- Valentina A. ValovaVVValentina A. Valova
- Phillip J. RobinsonPRPhillip J. Robinson
- Juan‐Juan FengJFJuan‐Juan Feng
- Steven MarstonSMSteven Marston
- Kathryn NorthKNKathryn North
- 23 March 2007
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 61 (6) , 552-561
Abstract
Objective: Mutations in ACTA1 have been associated with a variety of changes in muscle histology that likely result from fundamental differences in the way that ACTA1 mutations disrupt muscle function. Recently, we reported three patients with congenital fiber type disproportion (CFTD) caused by novel heterozygous missense mutations in ACTA1 (D292V, L221P, P332S) with marked type 1 fiber hypotrophy as the only pathological finding on muscle biopsy. We have investigated the basis for the histological differences between these CFTD patients and patients with ACTA1 nemaline myopathy (NM).Methods and Results: Mass spectrometry and two‐dimensional gel electrophoresis demonstrate that mutant actin accounts for 25 and 50% of α‐skeletal actin in the skeletal muscle of patients with the P332S and D292V mutations, respectively, consistent with a dominant‐negative disease mechanism. In vitro motility studies indicate that abnormal interactions between actin and tropomyosin are the likely principal cause of muscle weakness for D292V, with tropomyosin stabilized in the “switched off” position. Both the D292V and P322S CFTD mutations are associated with normal sarcomeric structure on electron microscopy, which is atypical for severe NM. In contrast, we found no clear difference between ACTA1 mutations associated with NM and CFTD in tendency to polymerize or aggregate in C2C12 expression models.Interpretation: These data suggest that ACTA1 CFTD mutations cause weakness by disrupting sarcomere function rather than structure. We raise the possibility that the presence or absence of structural disorganization when mutant actin incorporates into sarcomeres may be an important determinant of whether the histological patterns of CFTD or NM develop in ACTA1 myopathy. Ann Neurol 2007Keywords
Funding Information
- National Health and Medical Research Council, Australia (206529, 372104)
- Muscular Dystrophy Association of New South Wales (Australia) (15/12/01)
- British Heart Foundation (RG/02010)
This publication has 24 references indexed in Scilit:
- Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutationNeuromuscular Disorders, 2006
- An Atomic Model of the Thin Filament in the Relaxed and Ca2+-Activated StatesJournal of Molecular Biology, 2006
- Defining α-skeletal and α-cardiac actin expression in human heart and skeletal muscle explains the absence of cardiac involvement in ACTA1 nemaline myopathyNeuromuscular Disorders, 2005
- E93K Charge Reversal on Actin Perturbs Steric Regulation of Thin FilamentsJournal of Molecular Biology, 2005
- Missense mutations of ACTA1 cause dominant congenital myopathy with coresJournal of Medical Genetics, 2004
- Heterogeneity of nemaline myopathy cases with skeletal muscle α‐actin gene mutationsAnnals of Neurology, 2004
- Evidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoformsHuman Molecular Genetics, 2004
- Alterations in Thin Filament Regulation Induced by a Human Cardiac Troponin T Mutant That Causes Dilated Cardiomyopathy Are Distinct from Those Induced by Troponin T Mutants That Cause Hypertrophic CardiomyopathyJournal of Biological Chemistry, 2002
- The Brain Exocyst Complex Interacts with RalA in a GTP-dependent MannerJournal of Biological Chemistry, 2001
- An Actin Subdomain 2 Mutation That Impairs Thin Filament Regulation by Troponin and TropomyosinJournal of Biological Chemistry, 2000